0001572426-15-000129.txt : 20151120 0001572426-15-000129.hdr.sgml : 20151120 20151120131030 ACCESSION NUMBER: 0001572426-15-000129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151120 FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heffernan Mark CENTRAL INDEX KEY: 0001632439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 151245942 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-11-20 0001618561 Nexvet Biopharma plc NVET 0001632439 Heffernan Mark C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 IRELAND 0 1 0 0 Chief Executive Officer Ordinary Shares 2015-11-20 4 M 0 9204 .125 A 243587 I By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C> Ordinary Shares 12084 D Option to Purchase Shares .125 2015-11-20 4 M 0 9204 0 D 2020-11-05 Ordinary Shares 9204 9203 I By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C> The reporting person and his spouse share voting and dispositive power with respect to these reported securities. Options to purchase 9,204 shares vested and became exercisable on 11/5/15, and the remaining 9,203 options to purchase shares will vest and become exercisable on 11/5/16. /s/ Mark Heffernan by Geraldine T. Farrell, Attorney-in-Fact 2015-11-20